Publication:
Suppressor of fused associates with dissemination patterns in patients with glioma

dc.contributor.authorPeris-Celda, María
dc.contributor.authorCarrión-Navarro, Josefa
dc.contributor.authorPalacín-Aliana, Irina
dc.contributor.authorSánchez-Gómez, Pilar
dc.contributor.authorPrat-Acín, Ricardo
dc.contributor.authorGarcía-Romero, Noemí
dc.contributor.authorAyuso-Sacido, Angel
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderBanco Santander
dc.contributor.funderFrancisco de Vitoria University (España)
dc.date.accessioned2023-04-27T09:05:50Z
dc.date.available2023-04-27T09:05:50Z
dc.date.issued2022-08
dc.description.abstractGliomas are the most common brain tumors, which present poor prognosis, due, in part, to tumor cell migration and infiltration into distant brain areas. However, the underlying mechanisms causing such effects are unknown. Hedgehog (HH)-Gli axis is one of the signaling pathways involved, with a high number of molecular mediators. In this study, we investigated the association between HH-Gli intermediates and clinical parameters. We found that high levels of SuFu are associated with high dissemination patterns in patients with glioma. Therefore, we analyzed SuFu expression data in three glioma cohorts of surgical samples (N =1,759) and modified its expression in Glioblastoma Cancer Stem Cells (GB CSC) in vitro models. Our data reveal that SuFu overexpression increases cancer stemness properties together with a migratory phenotype. This work identifies SuFu as a new molecular player in glioma cell migration and a promising target to develop blocking agents to decrease GB dissemination.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis research was funded by grants from the "Proyectos de Investigación en Salud" (PI21/01353) and La Universidad Francisco de Vitoria-Banco Santander (UFV2021-23).es_ES
dc.format.page923681es_ES
dc.format.volume12es_ES
dc.identifier.citationFront Oncol. 2022 Aug 24;12:923681.es_ES
dc.identifier.doi10.3389/fonc.2022.923681es_ES
dc.identifier.issn2234-943Xes_ES
dc.identifier.journalFrontiers in oncologyes_ES
dc.identifier.pubmedID36091108es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15908
dc.language.isoenges_ES
dc.publisherFrontiers Media
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III///PI21 - Proyectos de investigacion en salud (AES 2021). Modalidad proyectos de investigación en salud. (2021)/PI21/01353es_ES
dc.relation.publisherversionhttps://doi.org/10.3389/fonc.2022.923681es_ES
dc.repisalud.centroISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSuFu = suppressor of fusedes_ES
dc.subjectBrain tumorses_ES
dc.subjectGlioblastomaes_ES
dc.subjectGliomaes_ES
dc.subjectHedgehog glioma-associated oncogene 1 (GLI1)es_ES
dc.subjectMigrationes_ES
dc.titleSuppressor of fused associates with dissemination patterns in patients with gliomaes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5149e567-93ff-423f-86af-68545f9abee7
relation.isAuthorOfPublication.latestForDiscovery5149e567-93ff-423f-86af-68545f9abee7
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication2302598f-47dd-49b5-a26e-ae31bf61786e
relation.isFunderOfPublicatione95317ff-7275-4386-b2ee-b58a480cd3d9
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
SuppressorFusedAssociatesDissemination_2022.pdf
Size:
3.18 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Supplementary_SuppressorFusedAssociatesDissemination_2022.pdf
Size:
764.28 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material